The reasons behind non-adherence are complex and include misconceptions about the consequences of missed doses, dissatisfaction with growth outcomes, a lack of understanding of the nature of the primary growth disorder and the rationale and evidence of benefit of hGH therapy and inadequate contact with a positive support from HCPs (16, 17). Here, GH1 is linked to hereditary endocrine growth disease.